BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35687490)

  • 1. Genomic characterization of lymphomas in patients with inborn errors of immunity.
    Ye X; Maglione PJ; Wehr C; Li X; Wang Y; Abolhassani H; Deripapa E; Liu D; Borte S; Du L; Wan H; Plötner A; Giannoula Y; Ko HB; Hou Y; Zhu S; Grossman JK; Sander B; Grimbacher B; Hammarström L; Fedorova A; Rosenzweig SD; Shcherbina A; Wu K; Warnatz K; Cunningham-Rundles C; Pan-Hammarström Q
    Blood Adv; 2022 Sep; 6(18):5403-5414. PubMed ID: 35687490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inborn errors of immunity and its clinical significance in children with lymphoma in China: a single-center study.
    Yang C; Li N; Zhang M; Huang S; Jin L; Liu SG; Zhou CJ; Li ZG; Duan YL
    J Pediatr (Rio J); 2024 Mar; ():. PubMed ID: 38547930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair genes are selectively mutated in diffuse large B cell lymphomas.
    de Miranda NF; Peng R; Georgiou K; Wu C; Falk Sörqvist E; Berglund M; Chen L; Gao Z; Lagerstedt K; Lisboa S; Roos F; van Wezel T; Teixeira MR; Rosenquist R; Sundström C; Enblad G; Nilsson M; Zeng Y; Kipling D; Pan-Hammarström Q
    J Exp Med; 2013 Aug; 210(9):1729-42. PubMed ID: 23960188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
    Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
    Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity of diffuse large B-cell lymphoma.
    Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Mieczkowski PA; Dunphy C; Choi W; Au WY; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers C; Naresh K; Evens A; Gordon LI; Czader M; Gill JI; Hsi ED; Liu Q; Fan A; Walsh K; Jima D; Smith LL; Johnson AJ; Byrd JC; Luftig MA; Ni T; Zhu J; Chadburn A; Levy S; Dunson D; Dave SS
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1398-403. PubMed ID: 23292937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic screening in a Brazilian cohort with inborn errors of immunity.
    Ferreira CS; Francisco Junior RDS; Gerber AL; Guimarães APC; de Carvalho FAA; Dos Reis BCS; Pinto-Mariz F; de Souza MS; de Vasconcelos ZFM; Goudouris ES; Vasconcelos ATR
    BMC Genom Data; 2023 Aug; 24(1):47. PubMed ID: 37592284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives.
    Aluri J; Cooper MA
    Semin Immunol; 2023 May; 67():101761. PubMed ID: 37062181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab.
    Kobayashi T; Tsutsumi Y; Sakamoto N; Nagoshi H; Yamamoto-Sugitani M; Shimura Y; Mizutani S; Matsumoto Y; Nishida K; Horiike S; Asano N; Nakamura S; Kuroda J; Taniwaki M
    Jpn J Clin Oncol; 2012 Nov; 42(11):1035-42. PubMed ID: 22984125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.
    Zama D; Conti F; Moratti M; Cantarini ME; Facchini E; Rivalta B; Rondelli R; Prete A; Ferrari S; Seri M; Pession A
    Immun Inflamm Dis; 2021 Jun; 9(2):583-594. PubMed ID: 33838017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of malignancies in patients with different types of inborn errors of immunity.
    Tavakol M; Delavari S; Salami F; Ansari S; Rasouli SE; Chavoshzadeh Z; Sherkat R; Ahanchian H; Aleyasin S; Esmaeilzadeh H; Moazzen N; Shafiei A; Abolnezhadian F; Iranparast S; Ebrahimi SS; Moeini Shad T; Pashangzadeh S; Nazari F; Rezaei A; Saeedi-Boroujeni A; Nabavi M; Arshi S; Fallahpour M; Bemanian MH; Sharafian S; Shokri S; Eshaghi S; Nazari S; Shamsian BS; Dargahi Mal-Amir M; Khazaei R; Ashkevari P; Khavandegar A; Haghi S; Esmaeili M; Abolhassani H; Rezaei N
    Allergy Asthma Clin Immunol; 2022 Dec; 18(1):106. PubMed ID: 36510326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.
    Hathcock KS; Padilla-Nash HM; Camps J; Shin DM; Triner D; Shaffer AL; Maul RW; Steinberg SM; Gearhart PJ; Staudt LM; Morse HC; Ried T; Hodes RJ
    Blood; 2015 Nov; 126(20):2291-301. PubMed ID: 26400962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.
    Kim SH; Cheong JW; Park KH; Kim TS; Yang WI
    Arch Pathol Lab Med; 2007 Mar; 131(3):457-67. PubMed ID: 17516749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomics in inborn errors of immunity.
    Hurabielle C; LaFlam TN; Gearing M; Ye CJ
    Immunol Rev; 2024 Mar; 322(1):53-70. PubMed ID: 38329267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity.
    Cooper MA; Zimmerman O; Nataraj R; Wynn RF
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):628-639. PubMed ID: 33551038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complementary approach for genetic diagnosis of inborn errors of immunity using proteogenomic analysis.
    Sakura F; Noma K; Asano T; Tanita K; Toyofuku E; Kato K; Tsumura M; Nihira H; Izawa K; Mitsui-Sekinaka K; Konno R; Kawashima Y; Mizoguchi Y; Karakawa S; Hayakawa S; Kawaguchi H; Imai K; Nonoyama S; Yasumi T; Ohnishi H; Kanegane H; Ohara O; Okada S
    PNAS Nexus; 2023 Apr; 2(4):pgad104. PubMed ID: 37077884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
    Laurent C; Syrykh C; Hamon M; Adélaïde J; Guille A; Escudié F; Jalowicki G; Fina F; Bardet A; Mescam L; Molina TJ; Dartigues P; Parrens M; Sujobert P; Besson C; Birnbaum D; Xerri L
    Am J Surg Pathol; 2022 Jun; 46(6):742-753. PubMed ID: 34799485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection.
    Driessen A; Tierens A; Ectors N; Stul M; Pittaluga S; Geboes K; Delabie J; De Wolf-Peeters C
    Leukemia; 1999 Jul; 13(7):1085-92. PubMed ID: 10400425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations predisposing to diffuse large B-cell lymphoma.
    Leeksma OC; de Miranda NF; Veelken H
    Blood Cancer J; 2017 Feb; 7(2):e532. PubMed ID: 28211887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.